Please login to the form below

Not currently logged in
Email:
Password:

Philidor

This page shows the latest Philidor news and features for those working in and with pharma, biotech and healthcare.

Valeant's ex-CEO and CFO 'could face criminal charges'

Valeant's ex-CEO and CFO 'could face criminal charges'

Sources suggest probe may relate to the company’s former relationship with Philidor Rx Services. ... 2014 and 2015, admitting that it recorded $58m in revenue from Philidor earlier than it should have.

Latest news

  • Valeant shares slide on fears of filing default Valeant shares slide on fears of filing default

    Meanwhile, investors in Valeant have faced months of uncertainty amid a congressional investigation into its pricing policy for drugs and a controversial relationship with specialty pharmacy chain Philidor - now dissolved - which ... ad hoc committee set

  • As CEO returns, Valeant admits SEC probe As CEO returns, Valeant admits SEC probe

    The company is already under scrutiny over its (now terminated) relationship with specialty pharmacy chain Philidor - said to have inflated its reported revenues - and has had to withdraw its financial guidance ... Valeant has remained tight-lipped about

  • Valeant names Schiller interim CEO as Pearson battles illness Valeant names Schiller interim CEO as Pearson battles illness

    prices as well as allegations - hotly disputed - that it had used mail-order pharmacy Philidor Rx  to inflate revenues.

  • PBMs drop Philidor, and Valeant follows suit PBMs drop Philidor, and Valeant follows suit

    Comes after allegations of impropriety. It seems Valeant's insistence earlier this week that its relationship with specialty pharmacy Philidor was above board failed to convince pharmacy benefit managers. ... The three largest PBMs in the US - CVS,

  • Valeant shares plummet on claims of inflated revenues Valeant shares plummet on claims of inflated revenues

    California lawsuit raises questions about relationship with Philidor Rx. Valeant has been hit by claims that it is using specialty pharmacies to artificially inflate its revenues, although it disputes the allegations. ... The suit - which is seeking

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics